Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 5 studies | 19% ± 2% |
Insufficient scRNA-seq data for expression of IFIH1 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 865.83 | 1445 / 1445 | 99% | 30.24 | 182 / 183 |
stomach | 100% | 800.50 | 359 / 359 | 98% | 19.95 | 281 / 286 |
breast | 100% | 1056.97 | 459 / 459 | 98% | 39.32 | 1098 / 1118 |
prostate | 100% | 752.58 | 245 / 245 | 98% | 19.14 | 490 / 502 |
thymus | 100% | 1001.97 | 653 / 653 | 97% | 18.12 | 585 / 605 |
lung | 100% | 1377.42 | 578 / 578 | 96% | 23.60 | 1112 / 1155 |
pancreas | 99% | 693.86 | 326 / 328 | 96% | 22.24 | 171 / 178 |
intestine | 100% | 980.61 | 966 / 966 | 95% | 18.35 | 499 / 527 |
kidney | 100% | 921.16 | 89 / 89 | 94% | 19.45 | 844 / 901 |
uterus | 100% | 938.19 | 170 / 170 | 93% | 27.37 | 429 / 459 |
ovary | 100% | 861.27 | 180 / 180 | 92% | 22.86 | 394 / 430 |
liver | 100% | 650.49 | 226 / 226 | 86% | 12.33 | 351 / 406 |
bladder | 100% | 639.14 | 21 / 21 | 85% | 19.19 | 430 / 504 |
skin | 98% | 625.87 | 1778 / 1809 | 85% | 25.41 | 400 / 472 |
adrenal gland | 99% | 1112.92 | 256 / 258 | 81% | 12.82 | 187 / 230 |
brain | 85% | 350.52 | 2247 / 2642 | 78% | 11.35 | 553 / 705 |
adipose | 100% | 1059.30 | 1204 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 34.61 | 29 / 29 |
spleen | 100% | 1842.07 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 39.89 | 45 / 45 |
blood vessel | 100% | 862.55 | 1333 / 1335 | 0% | 0 | 0 / 0 |
heart | 97% | 434.63 | 836 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 86% | 2427.95 | 799 / 929 | 0% | 0 | 0 / 0 |
muscle | 50% | 121.37 | 399 / 803 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 34% | 3.54 | 27 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0016925 | Biological process | protein sumoylation |
GO_0034344 | Biological process | regulation of type III interferon production |
GO_0045071 | Biological process | negative regulation of viral genome replication |
GO_0032728 | Biological process | positive regulation of interferon-beta production |
GO_0032755 | Biological process | positive regulation of interleukin-6 production |
GO_0045087 | Biological process | innate immune response |
GO_0009615 | Biological process | response to virus |
GO_0051607 | Biological process | defense response to virus |
GO_0060760 | Biological process | positive regulation of response to cytokine stimulus |
GO_0032727 | Biological process | positive regulation of interferon-alpha production |
GO_0009597 | Biological process | detection of virus |
GO_0098586 | Biological process | cellular response to virus |
GO_0051259 | Biological process | protein complex oligomerization |
GO_0060337 | Biological process | type I interferon-mediated signaling pathway |
GO_0071360 | Biological process | cellular response to exogenous dsRNA |
GO_0032760 | Biological process | positive regulation of tumor necrosis factor production |
GO_0002753 | Biological process | cytoplasmic pattern recognition receptor signaling pathway |
GO_0039530 | Biological process | MDA-5 signaling pathway |
GO_0140374 | Biological process | antiviral innate immune response |
GO_0005739 | Cellular component | mitochondrion |
GO_0005829 | Cellular component | cytosol |
GO_0005737 | Cellular component | cytoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0003677 | Molecular function | DNA binding |
GO_0038187 | Molecular function | pattern recognition receptor activity |
GO_0003727 | Molecular function | single-stranded RNA binding |
GO_0003724 | Molecular function | RNA helicase activity |
GO_0043021 | Molecular function | ribonucleoprotein complex binding |
GO_0042802 | Molecular function | identical protein binding |
GO_0008270 | Molecular function | zinc ion binding |
GO_0005524 | Molecular function | ATP binding |
GO_0003723 | Molecular function | RNA binding |
GO_0005515 | Molecular function | protein binding |
GO_0016887 | Molecular function | ATP hydrolysis activity |
GO_0003725 | Molecular function | double-stranded RNA binding |
Gene name | IFIH1 |
Protein name | Interferon induced with helicase C domain 1 Interferon-induced helicase C domain-containing protein 1 (EC 3.6.4.13) (Clinically amyopathic dermatomyositis autoantigen 140 kDa) (CADM-140 autoantigen) (Helicase with 2 CARD domains) (Helicard) (Interferon-induced with helicase C domain protein 1) (Melanoma differentiation-associated protein 5) (MDA-5) (Murabutide down-regulated protein) (RIG-I-like receptor 2) (RLR-2) (RNA helicase-DEAD box protein 116) RNA helicase (EC 3.6.4.13) |
Synonyms | MDA5 RH116 |
Description | FUNCTION: Innate immune receptor which acts as a cytoplasmic sensor of viral nucleic acids and plays a major role in sensing viral infection and in the activation of a cascade of antiviral responses including the induction of type I interferons and pro-inflammatory cytokines . Its ligands include mRNA lacking 2'-O-methylation at their 5' cap and long-dsRNA (>1 kb in length) . Upon ligand binding it associates with mitochondria antiviral signaling protein (MAVS/IPS1) which activates the IKK-related kinases: TBK1 and IKBKE which phosphorylate interferon regulatory factors: IRF3 and IRF7 which in turn activate transcription of antiviral immunological genes, including interferons (IFNs); IFN-alpha and IFN-beta. Responsible for detecting the Picornaviridae family members such as encephalomyocarditis virus (EMCV), mengo encephalomyocarditis virus (ENMG), and rhinovirus . Detects coronavirus SARS-CoV-2 . Can also detect other viruses such as dengue virus (DENV), west Nile virus (WNV), and reovirus. Also involved in antiviral signaling in response to viruses containing a dsDNA genome, such as vaccinia virus. Plays an important role in amplifying innate immune signaling through recognition of RNA metabolites that are produced during virus infection by ribonuclease L (RNase L). May play an important role in enhancing natural killer cell function and may be involved in growth inhibition and apoptosis in several tumor cell lines. . |
Accessions | A0A3B3IRK8 ENST00000421365.2 [Q9BYX4-2] ENST00000649979.2 [Q9BYX4-1] Q9BYX4 A0A7P0Z4A9 ENST00000697291.1 ENST00000648433.1 ENST00000679938.1 A0A8V8TKX2 |